MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma
University of Arkansas
University of Arkansas
M.D. Anderson Cancer Center
Medical College of Wisconsin
University of Alabama at Birmingham
University Hospital, Lille
City of Hope Medical Center
Thomas Jefferson University
University of Arkansas
Weill Medical College of Cornell University
University of Arkansas
University of Arkansas
City of Hope Medical Center
M.D. Anderson Cancer Center
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
Insel Gruppe AG, University Hospital Bern
University of Leeds
National Heart, Lung, and Blood Institute (NHLBI)
University of Nebraska
National Cancer Institute (NCI)
European Myeloma Network B.V.
Barbara Ann Karmanos Cancer Institute
Washington University School of Medicine
Duke University
Ohio State University Comprehensive Cancer Center
Canadian Cancer Trials Group
Fondazione EMN Italy Onlus
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Boston Medical Center
Northside Hospital, Inc.
National Heart, Lung, and Blood Institute (NHLBI)
University of Liege
University Health Network, Toronto
PETHEMA Foundation
Memorial Sloan Kettering Cancer Center
Swedish Medical Center
Hackensack Meridian Health
University of Iowa
City of Hope Medical Center
University of Arkansas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Southampton
Boston Medical Center
Albert Einstein College of Medicine
University of Arkansas
M.D. Anderson Cancer Center
Acrotech Biopharma Inc.
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center